WiLing Wednesdays Education Webinars
Women in Lymphoma is very grateful for the generous sponsorship from industry supporters around the world.
Thank you for your ongoing support of our projects!
WiLing Wednesdays educational webinars hosted by Women in Lymphoma are solely intended for professionals working in the field of lymphoma. All patients seeking guidance or support with a lymphoma diagnosis or treatment are advised to consult their specialist haematologist.
______________________________________________________________________________________________
SERIES 14 - DEMYSTIFYING PHARMA - Apr/May 2025
Session 1 recording
Pharma Structure - Michelle Dawson, Nina Shah
Session 2 recording
Industry Engagement - Clare Spooner, John Wahba, Suhaida Selamat
Session 3 recording
Successful Research Collaboration - Julia Brain, Candice McCoy
Session 4 recording
Careers in Pharma - Connie Batlevi, Jamie Hirata
SERIES 13 - INDOLENT LYMPHOMA - Oct/Nov 2024
Session 1 recording
First step of lymphomagenesis (t14;18 & CREBBP) - Dr. Sandrine Roulland & The CPC in its niche - Dr. Karin Tarte
Session 2 recording
Biological Determinants of Progression and Transformation of Follicular Lymphoma - Prof. Jess Okosun & Risk stratification versus genomic classification in FL - Carla Casulo, MD
Session 3 recording
First line for LTB & HTB - Dr Clémentine Sarkozy & RELEVANCE and preliminary data on PET as a biomarker, including its combination with ctDNA, recent advances in radiomics - Dr Anne-Ségolène Cottereau
Session 4 recording
DEBATE : High risk relapsed FL should be treated differently
FOR – Dr Kim Linton & AGAINST – Dr Astrid Pavlovsky
Session 5 recording
Career Development
SERIES 12 - HODGKIN LYMPHOMA - May/June 2024
Session 1 recording
Strategies to Tailor Treatment for Hodgkin Lymphoma
Session 2 recording
Global Perspectives on Treatment of Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma with a Focus on Advanced Stage
Session 3 recording
Current/Forthcoming Clinical Trials in Hodgkin Lymphoma
Session 4 recording
Nodular Lymphoma Predominant Hodgkin Lymphoma and Other Pathologic Phenomena in Hodgkin Lymphoma
SERIES 11 – DLBCL - March/April 2024
Session 1 recording
Upfront DLBCL Therapy
Session 2 recording
The Changing Algorithm in R/R DLBCL
Session 3 recording
Expanding Novel Therapies in R/R DLBCL
Session 4 recording
Tailoring Therapy in R/R DLBCL
Session 5 recording
Update on DLBCL Classification
SERIES 10 – CAREER DEVELOPMENT - Oct/Nov 2023
Session 1 recording
Navigating early career development: Mentorship and Academic Promotion
Session 2 recording
Tips & Pearls for Publishing Success
Session 3 recording
Identifying and Pursuing Research Opportunities and Cooperative work
Session 4 recording
Making Meaning in the Second half of your Career – leadership planning and new experiences
SERIES 9 – MANTLE CELL LYMPHOMA (MCL) - May 2023
Session 1 recording
MCL Treatment
Session 2 recording
MCL Prognostication
Session 3 recording
Pathogenesis & Biology
SERIES 8 – CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) - Feb/Mar 2023
Session 1 recording
CLL frontline treatment/new drugs/global access
Session 2 recording
Tough CLL
Session 3 recording
Career Development
Session 4 recording
Optimal Investigation of CLL - molecular studies, risk stratification & MRD
SERIES 7 - LYMPHOMA & THE BRAIN - Sept/Oct 2022
Session 1 recording
PCSNL - Diagnosis and Treatment
Session 2 recording
PSNSL - Elderly and side effects
Session 3 recording
SCNSL and CAR-T
Session 4 recording
Debate on CNS Prophylaxis
Session 5 recording
Other brain lymphomas & imaging
SERIES 6 - CELLULAR THERAPY - Apr/May 2022
Session 1 recording
Defining Cellular Therapies
Session 2 recording
CAR-T Cells in different clinical settings - Treatment of DLBCL/Treatment of FL, MCL, CLL
Session 3 recording
Moving forward in CAR-T Cell - Mechanisms of Resistance/Modified CAR-T Strategies – Allo CAR-T, Dual CAR-T
Session 4 recording
CAR-T Strategies vs. BiTes
Session 5 recording
Global discussion on access, application, real-life experiences & challenges
SERIES 5 - CAREER DEVELOPMENT - Mar/Apr 2022
Session 1 recording
APPs
Session 2 recording
Legendary WiL
SERIES 4 – INDOLENT LYMPHOMA - Oct/Nov 2021
Session 1 recording
Living with Follicular Lymphoma/Follicular Lymphoma pathogenesis and clonal evolution, transformed FL
Session 2 recording
Risk stratification in Follicular Lymphoma/Utility of PET in Follicular Lymphoma
Session 3 recording
Advances for treatment for Follicular Lymphoma/Treatment paradigms for relapsed and refractory Follicular Lymphoma
Session 4A recording
Career Development with Change Champions and their Mentees
Session 4B recording
Career Development with Change Champions and their Mentees
Session 5 recording
Treatment options in Marginal Zone Lymphoma/Waldenstrom’s Macroglobulinemia
SERIES 3 - T-CELL LYMPHOMA - Apr/May 2021
Session 1 recording
Update on T-cell : Lymphoma HemPath review/Primary therapy of common peripheral T-cell lymphoma
Session 2 recording
HemPath review of T-cell lymphomas common in Asia/Frontline & Salvage therapies for T-cell lymphomas common in Asia
Session 3 recording
Treatment & outcome for relapsed T-cell lymphomas/Use of autologous & allogenuc transplant for T-cell lymphomas
Session 4 recording
Newer therapies & Clinical trials for T-cell lymphomas/Case studies of T-cell lymphomas
Session 5 recording
Career Development
SERIES 2 - HODGKIN LYMPHOMA - Jan/Feb 2021
Session 1 recording
Harnessing The Immune System To Treat Hodgkin Lymphoma
Session 2 recording
Radiation In HL: A Showcase Of An Ideal Therapeutic Ratio
Session 3 recording
Optimising The Care Of Aya Hodgkin Lymphoma
Session 4 recording
Hodgkin Lymphoma Cases: A Global Discussion
Session 5 recording
Career Reflections
SERIES 1 - DLBCL - Sept 2020
Unfortunately recordings are not available for this series.
Session 1
How I Approach Newly Diagnosed DLBCL
Session 2
How I manage relapsed DLBCL
Session 3
PET-pearls & PET-pitfalls in DLBCL
Session 4
DLBCL: Lessons learnt from LYSA clinical trials
Session 5
CNS Prophylaxis in Diffuse Large B Cell Lymphoma